Behind the Breakthroughs and Practice-Changing Advances: Insights from ESMO 2024
Intouch Solutions
SEPTEMBER 27, 2024
Our industry is making great strides toward individualized therapies that tailor treatment plans to the unique genetic makeup of each patient’s tumor. ctDNA: New data was presented demonstrating major advances in the understanding of circulating tumor DNA (ctDNA). And that’s something new. And that’s, that’s a milestone.
Let's personalize your content